Article
Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry - 1 Jan 2019
Zai Clement C, Tiwari Arun K, Chowdhury Nabilah I, Yilmaz Zeynep, de Luca Vincenzo, Müller Daniel J, Potkin Steven G, Lieberman Jeffrey A, Meltzer Herbert Y, Voineskos Aristotle N, Remington Gary, Kennedy James L
Abstract excerpt
OBJECTIVES: Tardive dyskinesia (TD) is a movement disorder that may develop as a side effect of antipsychotic medication. The aetiology underlying TD is unclear, but a number of mechanisms have been proposed. METHODS: We investigated single-nucleotide polymorphisms (SNPs) in the genes coding for neuregulin-1 and erbB-4 receptor in our sample of 153 European schizophrenia patients for possible association with TD....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.